
Keywords: قمار استاندارد; prostatic neoplasms; United States Food and Drug Administration; patient preference; clinical decision making; equipment and supplies; AS; active surveillance; BOO; bladder outlet obstruction; FDA; Food and Drug Administration; HIFU; high intensity focuse